| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Jian,Yuan-Cheng | Chairman | 13.86% | HE RUN INVESTMENT CO., LTD. |
| Jian,Wen-Jie | Director | 10.29% | CHUN YU INVESTMENT LTD. |
| Jian,Tian-Min | Director | 13.86% | MIN WEI INVESTMENT CO., LTD. |
| Ma,Xiao-En | Director | 13.86% | ZHENG YI INVESTMENT LTD. |
| Wei,Cheng-Da | Director | 10.38% | DA RONG FA INVESTMENT LTD. |
| Lin,Po-Zhen | Director | 0.00% | |
| Jian,Wen-Yu | Independent Director | 0.00% | |
| Lin,Zhao-Zheng | Independent Director | 0.00% | |
| Yang,Tian-Gui | Independent Director | 0.00% |
Change Company Name to Sun Brothers Development Co., Limited
2024/07/12
Change Company Name to SENBAO DEVELOPMENT CO., LTD. (FORMER NAME: QUANBAO ELECTRONICS CO., LTD.)
2022/06/14
Change Person in Charge to Jian,Yuan-Cheng
2021/08/10
Change Capital to 2,000,000,000
2020/07/06
Change Person in Charge to Jian,Zheng-De
2018/06/20
Change Person in Charge to Jian,Yuan-Cheng
2015/06/09
Change Company Name to Sun Brothers Development Co., Limited
2013/06/28
Change Person in Charge to Jian,Zheng-Xiong
2013/01/21
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 122,204 | 2,383,837 | 741,504 |
| Operating cost | 119,577 | 2,301,485 | 695,820 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 2,627 | 82,352 | 45,684 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 2,627 | 82,352 | 45,684 |
| Operating expenses | 7,109 | 133,257 | 54,781 |
| Other gain (loss), net | 135 | - | - |
| Operating profit (loss) | -4,347 | -50,905 | -9,097 |
| Non-operating income and expenses | 2,267 | 2,691 | 33,522 |
| Net profit (loss) before tax | -2,080 | -48,214 | 24,425 |
| Income tax expense (benefits) | 1,819 | 31,893 | 14,649 |
| Net profit (loss) of ongoing business for the current period | -3,899 | -80,107 | 9,776 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -3,899 | -80,107 | 9,776 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -3,899 | -80,107 | 9,776 |
| Net profit (loss) attributable to owners of parent company | -3,899 | -80,107 | 9,776 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | 0 |
| Net profit (loss) attributable to non-controlling interests | - | - | 0 |
| Comprehensive profit (loss) attributable to owners of parent company | -3,899 | -80,107 | 9,776 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | 0 |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | 0 |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -52,010 | 1,061,520 | 39,321 |
| Net cash inflows (outflows) from investing activities | -154 | 862 | -775 |
| Net cash inflow (outflow) from financing activities | 27,063 | -897,903 | 277,158 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -25,101 | 164,479 | 315,704 |
| Beginning balance of cash and cash equivalents | 898,533 | 734,054 | 418,350 |
| Ending balance of cash and cash equivalents | 873,432 | 898,533 | 734,054 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 3,661,090 | 3,643,343 | 4,505,978 |
| Non-current asset | 197,809 | 197,879 | 191,840 |
| Total asset | 3,858,899 | 3,841,222 | 4,697,818 |
| Current liability | 2,600,508 | 2,579,140 | 3,015,005 |
| Non-current liability | 3,459 | 3,251 | 307,694 |
| Total liability | 2,603,967 | 2,582,391 | 3,322,699 |
| share capital | 904,522 | 904,522 | 904,522 |
| Equity - secruity token | - | - | - |
| capital reserve | 331,319 | 331,319 | 358,455 |
| retained earning | 19,091 | 22,990 | 112,142 |
| Other equity | - | - | - |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,254,932 | 1,258,831 | 1,375,119 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,254,932 | 1,258,831 | 1,375,119 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 13 | 13 | 15 |
